CALGARY, AB / ACCESSWIRE / April 1, 2019 / Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTC PINK: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), a licensed cultivation and processor under the Cannabis Act, has completed its first shipment of Adult-Use cannabis to the province of Saskatchewan.
Experion’s retail brand Citizen Stash has now been shipped to its provincial wholesale partner Open Fields in Saskatchewan and will be available online and at selected retail locations throughout the province. Over 8 kilograms was shipped consisting of approximately 3,500 units of 1- and 3.5-gram packages. The shipment contained Citizen Stash’s retail strain Lemon Zkittle which is a hybrid consisting of approximately 60% sativa with mid to high THC levels, a sour citrus aroma and a distinct lemon taste. The strain will offer recreational adult users a product that is relaxing and consistent in its quality and effects. Lemon Zkittle is already offered in the Province of British Columbia through the British Columbia Liquor Control Branch with several re-orders already received since its original shipment in February 2019.
Lemon Zkittle will be available in dried flower, however, Experion is actively working on pre-rolls and oils to complement the offering.
Jay Garnett, President and CEO commented, “The launch of our retail product in a second province signifies our continued commitment towards distribution across Canada and builds our brand recognition in the Adult-Use market. This, along with the quick sell out and re-orders in the BC market, validates that our first retail strain offering, Lemon Zkittle, as a positive experience in the Adult-Use market. We are looking forward to introducing further strains and products and will inform the market as they become available.”
Viridium Pacific Group Ltd. is the parent company of Experion Biotechologies Inc., a Health Canada licensed cultivation and processor of cannabis, based in Mission, BC and EFX labs, a medical products production and clinical research company based out of Calgary, AB.
More information about Viridium can be found under the Company’s profile on SEDAR at www.sedar.com.
For further information:
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.
SOURCE: Viridium Pacific Group Ltd.
View source version on accesswire.com: